EnsoData Receives Financing From CIBC Innovation Banking

The company plans to use the funding to grow its operations and continue investing in research and development.

EnsoData is improving sleep medicine with AI-powered, FDA-cleared tools that simplify and make diagnosis more accessible. Its main product, EnsoHST, is a home sleep test that uses a wearable device and a mobile app to deliver fast, reliable clinical results over multiple nights.

By automating data analysis and reducing operational complexity, EnsoData helps clinicians handle more patients, speed up diagnoses, and improve overall care outcomes.

"This facility from CIBC Innovation Banking enables EnsoData to expand access to the sleep care pathway today, while accelerating our investment in AI-driven innovations that will shape the future of diagnostics across multiple clinical domains," said Matt Dobereiner, CFO of EnsoData.

Read More:Oishii Raises $150M in Series C First Close

"CIBC Innovation Banking is very glad to support EnsoData’s growth and continued adoption among sleep medicine professionals,” said Andrew Schwartz, Managing Director, CIBC Innovation Banking. “EnsoData is at the exciting intersection of leveraging AI and machine-learning technology to improve access for patients to the care pathway."

About EnsoData

Founded in 2015 by Chris Fernandez, Sam Rusk and Nick Glattard, EnsoData is a healthcare technology company that uses artificial intelligence to advance sleep medicine. Its platform supports the full care journey, from diagnosis to long term patient management, helping clinicians improve efficiency and expand access to care. The company is also expanding into other clinical areas, and its technology has supported the care of more than 2.9 million patients to date.

About CIBC Innovation Banking

CIBC Innovation Banking has more than 25 years of experience supporting growth stage technology and life science companies across North America. The group currently manages over $11 billion in funds across sectors, including life sciences, healthcare, and cleantech and works with investors and entrepreneurs. Over the past six and a half years, it has supported more than 700 venture and private equity backed companies.

Read More:QuartzBio Receives Growth Investment from Eir Partners